High Intensity Focused Ultrasound (HIFU) is an innovative, non-invasive prostate cancer treatment. This treatment uses ultrasound waves to target specific cancerous cells without affecting the surrounding tissue. You can read more about The Sonablate 500 treatment of prostate cancer at Internationalhifu.com. The website provides a wealth of information about prostate cancer and the treatments available. It also provides a directory of doctors who perform the treatment with profiles of those doctors.
The Sonablate 500 is not approved for use in the United States. It is currently being studied and evaluated through clinical trials as required to get FDA approval. The FDA FDA has made no decision as to the safety or efficacy of the Sonablate 500 for the treatment of prostate cancer. Currently, the device is approved for the treatment of prostate cancer in Canada and the Dominican Republic, authorized in Argentina, and available in the Bahamas and Mexico.
